Indication
Pure red cell aplasia
Pure red cell aplasia is a rare hematologic syndrome characterized by a profound failure of erythropoiesis that selectively impacts the red blood cell lineage while preserving normal granulopoiesis and megakaryopoiesis. Read more about Pure red cell aplasia
145 drugs 92 manufacturers
Drugs that treat it
Common Pure red cell aplasia therapies.
DEXAMETHASONE
DEXAMETHASONE
HYDROCORTISONE SOD SUCCINATE (hydrocortisone sodium succinate)
DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/PF)
DEXAMETHASONE
METHYLPREDNISOLONE ACETATE
METHYLPREDNISOLONE ACETATE
DEXAMETHASONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPure red cell aplasia is a rare hematologic syndrome characterized by a profound failure of erythropoiesis that selectively impacts the red blood cell lineage while preserving normal granulopoiesis and megakaryopoiesis.
It can manifest in pediatric populations as a congenital disorder, such as Diamond-Blackfan anemia, or in adults as an acquired condition secondary to autoimmune diseases, thymomas, lymphoproliferative disorders, viral infections like parvovirus B19, or adverse drug reactions.
Pathophysiologically driven by immune-mediated, clonal, or direct cytotoxic destruction and maturation arrest of erythroid progenitors, the condition is clinically defined by severe normocytic normochromic anemia, profound reticulocytopenia, and a near-complete absence of erythroblasts in an otherwise cellular bone marrow.
- nih.gov
Pure red cell aplasia is a rare hematologic syndrome characterized by a profound failure of erythropoiesis that selectively impacts the red blood cell lineage while preserving normal granulopoiesis and megakaryopoiesis Pathophysiologically driven by immune-mediated, clonal, or direct cytotoxic destruction and maturation arrest of erythroid progenitors, the condition is clinically defined by severe normocytic normochromic anemia, profound reticulocytopenia, and a near-complete absence of erythrob...
- nih.gov
It can manifest in pediatric populations as a congenital disorder, such as Diamond-Blackfan anemia, or in adults as an acquired condition secondary to autoimmune diseases, thymomas, lymphoproliferative disorders, viral infections like parvovirus B19, or adverse drug reactions Pathophysiologically driven by immune-mediated, clonal, or direct cytotoxic destruction and maturation arrest of erythroid progenitors, the condition is clinically defined by severe normocytic normochromic anemia, profound ...
- nih.gov
It can manifest in pediatric populations as a congenital disorder, such as Diamond-Blackfan anemia, or in adults as an acquired condition secondary to autoimmune diseases, thymomas, lymphoproliferative disorders, viral infections like parvovirus B19, or adverse drug reactions
Personalize your experience
Follow Pure red cell aplasia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.